Computational, Experimental, and Clinical Evidence of a Specific but Peculiar Evolutionary Nature of (COVID-19) SARS-CoV-2

被引:6
|
作者
Goh, Gerard Kian-Meng [6 ]
Dunker, A. Keith [1 ]
Foster, James A. [2 ,3 ]
Uversky, Vladimir N. [4 ,5 ]
机构
[1] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA
[2] Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA
[3] Univ Idaho, Inst Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA
[4] Univ S Florida, Morsani Coll Med, USF Hlth Byrd Alzheimers Res Inst, Dept Mol Med, Tampa, FL 33620 USA
[5] Russian Acad Sci, Fed Res Ctr, Inst Biol Instrumentat, Lab New Methods Biol,Pushchino Sci Ctr Biol Res, Pushchino 142290, Russia
[6] Gohs BioComp, Singapore 548957, Singapore
关键词
pangolin; intrinsic; disorder; protein; nucleocapsid; virulence; shell; COVID; coronavirus; vaccine; immune; antibody; nucleoprotein; membrane; matrix; attenuate; severe acute respiratory; omicron; MOLECULAR RECOGNITION FEATURES; INTRINSIC DISORDER; PROTEINS; NUCLEOPROTEIN; VIRULENCE; BINDING; VIRUS; ROLES; MORFS;
D O I
10.1021/acs.jproteome.2c00001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The shell disorder models have predicted that SARS-CoV-2 is of a specific but peculiarevolutionary nature. All coronaviruses (CoVs) closely related to SARS-CoV-2 have been found to have thehardest outer shells (M protein) among CoVs. This hard shell (low M percentage of intrinsic disorder(PID)) is associated with burrowing animals, for example, pangolins, and is believed to be responsible forthe high contagiousness of SARS-CoV-2 because it will be more resistant to antimicrobial enzymes found insaliva/mucus. Incoming clinical and experimental data do support this along with a prediction based onanother aspect of the shell (N, inner shell) disorder models that SARS-CoV-1 is more virulent than SARS-CoV-2 because SARS-CoV-2 produces fewer virus copies in vital organs even if large amounts of infectionsparticles are shed orally and nasally. A phylogenetic study using M reveals a closer relationship of SARS-CoV to pangolin-CoVs than the bat-RaTG13 found in Yunnan, China. Previous studies may have beenconfused by recombinations that were poorly handled. The shell disorder models suggest that a pangolin-CoV strain may have entered the human population in 2017 or before as an attenuated virus, which couldexplain why SARS-CoV is found to be highly adapted to humans
引用
收藏
页码:874 / 890
页数:17
相关论文
共 50 条
  • [31] SARS-CoV-2 Targets and COVID-19 Vaccines
    Currier, Arthur W.
    Jeshurin, Madeline C.
    Sampson, Valerie B.
    COVID, 2021, 1 (03): : 608 - 621
  • [32] Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19
    Ribeiro da Silva, Severino Jefferson
    Alves da Silva, Caroline Targino
    Guarines, Klarissa Miranda
    Germano Mendes, Renata Pessoa
    Pardee, Keith
    Kohl, Alain
    Pena, Lindomar
    ACS INFECTIOUS DISEASES, 2020, 6 (09): : 2319 - 2336
  • [33] Decoding Covid-19 with the SARS-CoV-2 Genome
    Ellis, Phoebe
    Somogyvari, Ferenc
    Virok, Dezso P.
    Noseda, Michela
    McLean, Gary R.
    CURRENT GENETIC MEDICINE REPORTS, 2021, 9 (01) : 1 - 12
  • [34] SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
    Dhakal, Bishnu P.
    Sweitzer, Nancy K.
    Indik, Julia H.
    Acharya, Deepak
    William, Preethi
    HEART LUNG AND CIRCULATION, 2020, 29 (07) : 973 - 987
  • [35] Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review
    Suhail, Shanzay
    Zajac, Jonathan
    Fossum, Carl
    Lowater, Harrison
    McCracken, Cailin
    Severson, Nathaniel
    Laatsch, Bethany
    Narkiewicz-Jodko, Alex
    Johnson, Benjamin
    Liebau, Jessica
    Bhattacharyya, Sudeep
    Hati, Sanchita
    PROTEIN JOURNAL, 2020, 39 (06) : 644 - 656
  • [36] Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
    Fernandes, Queenie
    Inchakalody, Varghese Philipose
    Merhi, Maysaloun
    Mestiri, Sarra
    Taib, Nassiba
    El-Ella, Dina Moustafa Abo
    Bedhiafi, Takwa
    Raza, Afsheen
    Al-Zaidan, Lobna
    Mohsen, Mona O.
    Al-Nesf, Mariam Ali Yousuf
    Hssain, Ali Ait
    Yassine, Hadi Mohamad
    Bachmann, Martin F.
    Uddin, Shahab
    Dermime, Said
    ANNALS OF MEDICINE, 2022, 54 (01) : 524 - 540
  • [37] SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus
    Van Vo, Giau
    Bagyinszky, Eva
    Park, Yoon Soo
    Hulme, John
    An, Seong Soo A.
    CLINICAL, BIOLOGICAL AND MOLECULAR ASPECTS OF COVID-19, 2021, 1321 : 3 - 19
  • [38] Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery
    Sternberg, Ariane
    McKee, Dwight L.
    Naujokat, Cord
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (16) : 1423 - 1433
  • [39] SARS-CoV-2 and acute respiratory sindrome pandemic (COVID-19)
    Ruiz-Bravo, Alfonso
    Jimenez-Valera, Maria
    ARS PHARMACEUTICA, 2020, 61 (02) : 63 - 79
  • [40] The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2
    Amoutzias, Grigorios D.
    Nikolaidis, Marios
    Tryfonopoulou, Eleni
    Chlichlia, Katerina
    Markoulatos, Panayotis
    Oliver, Stephen G.
    VIRUSES-BASEL, 2022, 14 (01):